XML 19 R27.htm IDEA: XBRL DOCUMENT v3.20.1

10. SEGMENTS (Tables)

3 Months Ended

Mar. 31, 2020

Segment Reporting [Abstract]

Summarized segment financial information

Three Months Ended March 31, 2020
		ADMA BioManufacturing				Plasma Collection Centers				Corporate				Consolidated
Revenues		$	7,743,275			$	2,420,761			$	35,708			$	10,199,744
Cost of product revenue			14,451,954				2,377,272				—				16,829,226
Loss from operations			(12,476,144	)			(457,155	)			(3,836,487	)			(16,769,786	)
Interest and other expense, net			(238,873	)			—				(2,236,571	)			(2,475,444	)
Net loss			(12,715,017	)			(457,155	)			(6,073,058	)			(19,245,230	)
Capital expenditures			1,914,614				160,262				—				2,074,876
Depreciation and amortization expense			674,973				111,289				2,576				788,838
Total assets			104,645,897				5,376,807				100,501,123				210,523,827

Three Months Ended March 31, 2019
		ADMA BioManufacturing				Plasma Collection Centers				Corporate				Consolidated
Revenues		$	1,343,983			$	2,148,898			$	35,708			$	3,528,589
Cost of product revenue			7,940,346				1,464,833				—				9,405,179
(Loss) income from operations			(10,620,807	)			29,579				(2,617,188	)			(13,208,416	)
Interest and other (expense) income, net			(169,613	)			13,620				(1,268,472	)			(1,424,465	)
Gain on transfer of plasma center assets			—				11,527,421				—				11,527,421
Loss on extinguishment of debt			—				—				(9,962,495	)			(9,962,495	)
Net (loss) income			(10,790,420	)			11,570,620				(13,848,155	)			(13,067,955	)
Capital expenditures			110,453				—				—				110,453
Depreciation and amortization expense			687,393				114,241				3,696				805,330
Total assets			57,529,070				4,038,367				16,552,533				78,119,970

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8721-108599

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration